Kaiser launches COVID-19 vaccine trial for children 5 to 11

This year was a tough year for the 11-year-old Luci Guardino. Distance education was not easy and she couldn’t take her friends.

That’s why she’s participating in a COVID-19 vaccine trial in Sacramento, which began this week in a trio of Kaiser Permanente sites in Northern California, in children aged 5 to 11 years. She wants to allow others of her age to redo what she enjoyed before the pandemic.

“I definitely want to participate in the study to ensure that we return to normal life,” Luci, the daughter of Kaiser’s pediatrician, said at a press conference on Tuesday.

Luci is one of 75 children who will be enrolled in a survey that is also being conducted at the Kaiser site in Auckland and Santa Clara. This is part of a national effort involving approximately 4,600 children to evaluate the vaccine being developed by study sponsor Pfizer-BioNTech.

A few weeks ago, Kaiser’s Los Angeles Medical Center began a trial to evaluate the Modana vaccine in children aged 6 months to 11 years, according to a Kaiser spokeswoman. So far, Participants up to 6 years old have been registered.

At the Northern California site, two-thirds of participants receive the vaccine and the remaining one-third receive the placebo. Designed as a double-blind study, neither the clinician nor the patient knows if the vaccine is in a syringe. Clinicians collect data on the efficacy and safety of doses, including side effects.

After taking the first shot, Luci said her arms felt heavy, but she didn’t feel sick or had any other harmful symptoms.

If all the trials are successful, the vaccine may be available to young children as early as autumn, according to Dr. Nicola Klein, director of the Kaiser Permanente Vaccine Research Center, which is conducting the trial.

“So that might be the beginning of school,” Klein said, adding that timing is the best scenario and ultimately still “in the air.”

Pzizer has COVID-19 vaccine Approved for children over 12 years old. In April, Stanford began testing the Pfizer vaccine 2 year old childModerna Vaccine test for children March is 6 months to 11 years old.

The COVID-19 vaccine has generally proven to be very safe among more than 300 million Americans vaccinated, but according to Dr. Pia Pannaraj, a children’s hospital loss infectious disease specialist. It is still important to test separately in the younger age group Los Angeles.

“Since children are not small adults, it is unlikely that a vaccine that works for adults will work for children,” said Panna Raj, an associate professor of pediatrics at the hospital.

If the vaccine is approved for a younger age group, Pannaraj said the majority of children need to get it. She said that allergies to vaccine components are one of the few indicators of getting an injection.

In general, children are less likely to get coronavirus infections than adults, especially older adults. However, some people become ill enough to require hospitalization or intensive care.Ah Minority develops serious complications Not found in adults called multisystem inflammatory syndrome, or MIS-C, In essence their systemic inflammation.

Not only can it prevent serious complications, Pannaraj said, but vaccinated children can spread the virus to parents, grandparents, teachers, and others who can get worse. You can not.

It also helps bring children like Luci back to normal.

“Children need to be able to go back to school and play sports. In the summer there are pool parties and sleep parties,” she said. things. “

Kaiser launches COVID-19 vaccine trial for children 5 to 11 Source link Kaiser launches COVID-19 vaccine trial for children 5 to 11

Related Articles

Back to top button